An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy

• Xiao-Jian Ni ,

  Contributed equally to this work with: Xiao-Jian Ni, Xiao-Lan Zhang, Qian-Wen Ou-Yang

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xiao-Lan Zhang ,

  Contributed equally to this work with: Xiao-Jian Ni, Xiao-Lan Zhang, Qian-Wen Ou-Yang

  Affiliation Changzhou No 2 People’s Hospital Affiliated to Nanjing Medical University, Jiangsu, China

  ⨯
• Qian-Wen Ou-Yang ,

  Contributed equally to this work with: Xiao-Jian Ni, Xiao-Lan Zhang, Qian-Wen Ou-Yang

  Affiliation Department of Breast Surgery, the Third Hospital of Nanchang, Nanchang, Jiangxi, China

  ⨯
• Guo-Wei Qian,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Lei Wang,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Sheng Chen,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Yi-Zhou Jiang,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Wen-Jia Zuo,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Jiong Wu,

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xin Hu,

  Affiliation Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China

  ⨯
• Zhi-Ming Shao

  * E-mail: zhi_ming_shao@163.com

  Affiliations Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Institutes of Biomedical Science, Fudan University, Shanghai, China

  ⨯